Effect of Androgens on Anemia and Malnutrition in Renal Failure: Implications for Patients on Peritoneal Dialysis

Abstract

Objective To analyze the implications of the potential use of androgens in peritoneal dialysis patients, focusing on their effects on hematologic and nutritional parameters. This manuscript reviews the different compounds for clinical use, dosage schedules, adverse effects, and how therapy with androgens might be used to treat anemia and malnutrition in these dialysis patients. Data Sources Studies in the literature dealing with the effects of androgens on hematologic and nutritional parameters, and their role in uremic anemia and malnutrition. Study Selection Studies in which uremic patients received androgens as therapy for anemia or malnutrition. Data Extraction Data were abstracted from all of these studies. Results This review shows that androgens are anabolic substances that also have significant actions on erythropoiesis. A number of clinical studies in uremic patients have found that these compounds have beneficial effects on hematologic parameters and nutritional status, similarly to other therapies, such as recombinant human erythropoietin and recombinant human growth hormone, respectively. Conclusions Androgens have been shown to have a beneficial effect on anemia due to renal disease and on nutritional status in uremic patients. Further studies need to be done with larger groups of patients. Objectives for additional research are suggested.

Malnutrition-inflammation complex syndrome in dialysis patients: causes and consequences

“…121 Moreover, anabolic steroids have been administered successfully to simultaneously improve both nutritional state and anemia in dialysis patients. 122 Insulin-like growth factor 1 (IGF-1) is reported to enhance bone marrow progenitor-cell proliferation in uremic mice. 123 Hence, ESRD anemia may repre- sent both an EPO-and a functional IGF-1deficient state.…”

Effect of protein‐energy malnutrition on erythropoietin requirement in maintenance hemodialysis patients

“…Anabolic steroids have also been used to improve both nutritional state and anemia in dialysis patients. 12 We suggest a search for medical interventions that improve the nutritional status and suppress the microinflammation.…”

How Can Erythropoeitin‐Stimulating Agent Use be Reduced in Chronic Dialysis Patients?

“…As early as 1957, androgens were demonstrated to have a proerythropoietic effect . The mechanism is incompletely understood, but increased erythropoietin production, longer red cell life span and a direct effect on red cell precursors may contribute . These agents were used in hemodialysis patients prior to the availability of recombinant erythropoietin treatment.…”